๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Safety of large-volume leukapheresis for collection of peripheral blood progenitor cells

โœ Scribed by Rita A. Reik; Thomas A. Noto; Hugo F. Fernandez


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
37 KB
Volume
12
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

โœฆ Synopsis


Large volume leukapheresis (LVL) reduces the number of procedures required to obtain adequate peripheral blood progenitor cells (PBPCs) for autologous hematopoietic reconstitution. LVL involves the processing of >15 L or 5 patient blood volumes using high flow rates. We report our experience with LVL evaluating its efficiency and adverse effects in 71 adult patients with hematologic or solid organ malignancies. All were mobilized with chemotherapy and granulocyte colony-stimulating factor (G-CSF). All collections used a double lumen apheresis catheter. Mean values per LVL were as follows: blood processed, 24.6 L; patient blood volumes processed, 5.9; ACD-A used, 1,048 ml; heparin used, 6,148 units; collect time, 290 min; blood flow rate, 89 ml/min. Eighty percent of the collections were completed in one or two procedures to obtain เดœ6.0 ร— 10 8 MNCs/kg body weight. The most frequent side effect (39%) was parasthesia due to citrate-related hypocalcemia. This was managed with oral calcium supplements and/or slower flow rates. Post-LVL electrolyte changes were generally asymptomatic. Prophylactic oral potassium supplements were administered in 57% of cases. Other reactions included hypotension (4%), prolonged parasthesia (1.4%), and headache (1.4%). Catheter problems in 9 (13%) of the procedures were attributed to clot formation (37%) or positional effects (63%). No bleeding occurred. Post-LVL decreases in hematocrit and platelet count averaged 3.5% and 46%, respectively. Six (4%) of the procedures required red blood cell transfusions. Platelet transfusions were given in 19 (13%) of the procedures. We conclude that adverse reactions with LVL are similar to those reported for conventional PBPC collections, making it safe and efficacious as an outpatient procedure.


๐Ÿ“œ SIMILAR VOLUMES


Femoral vascular access for large-volume
โœ S. Shariatmadar; Thomas A. Noto ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 23 KB ๐Ÿ‘ 1 views

Central venous catheters are used frequently in large-volume leukapheresis to provide high flow rates for peripheral blood progenitor cell (PBPC) collection. In a retrospective study, we evaluated the safety and efficacy of short-term use of large-bore femoral venous catheters for the collection of

Large-volume leukapheresis procedure for
โœ Kanold, Justyna; Halle, Pascale; Berger, Marc; Rapatel, Chantal; Palcoux, Jean B ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 69 KB ๐Ÿ‘ 1 views

## Background: We update our experience on large-volume leukapheresis (lvl) in very small patients with malignancies. lvls were performed with the aim of reducing the psychological impact of leukaphereses by reducing the number of procedures while collecting large numbers of cells. ## Procedure:

Non-cryopreserved peripheral blood proge
โœ Christos A. Papadimitriou; Meletios A. Dimopoulos; Vassilios Kouvelis; Evangelos ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 38 KB ๐Ÿ‘ 2 views

High-dose chemotherapy with autologous peripheral blood progenitor cell (PBPC) support has become a widely used treatment strategy. In order to simplify the procedure, a single very large-volume leukapheresis programme combined with short-term refrigerated storage of the PBPC was developed. Seventy-

Pediatric large volume peripheral blood
โœ Jed B. Gorlin; Donald Humphreys; Patricia Kent; Dolores Galacki; Sherwin V. Kevy ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 801 KB

Collection of peripheral blood progenitor cells from small pediatric patients provides many social and technical challenges not faced when collecting from adult patients. This paper provides a single institutions experience with 85 collections from 14 patients less than 25 kg of weight over a 2 year

Determination of optimal timing of perip
โœ R.A. Anderson; T.R. Corr; K.R. Schultz; B.G. Massing; J.H. Davis; C.J.H. Fryer ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 157 KB

F'OS!l'ER ABSTRACTS =0.69), and with pre-harvest bD34+ count (r= 0.56). Peripheral Blood (PB) CD340t cell count and leukocyte count correlated poorly with the CD34+ cell count and CPU-GM of the collected product. We conclude that good correlation exists between PB leukocyte and CD34+ cell count with

Safety and efficacy of peripheral blood
โœ Sudha Sinha; Kian-Keong Poh; Donato Sodano; Janice Flanagan; Cindy Ouilette; Mar ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 89 KB

Information on the safety of mobilization and collection of peripheral blood progenitor cells (PBPC) in patients with advanced coronary heart disease (CHD) is limited. We report herein our early experience with patients participating in a Phase I trial of injection of autologous CD 34(+) cells into